Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease.

@article{EigerMoscovich2019ProstaglandinAD,
  title={Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease.},
  author={Maya Eiger-Moscovich and Hadas Stiebel-Kalish and Iftach Yassur and David Barash and Dan D. Gaton and Inbal Avisar},
  journal={Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
  year={2019},
  volume={54 4},
  pages={
          426-430
        }
}
OBJECTIVE Thyroid eye disease (TED) is characterized by an inflammatory response leading to soft tissue expansion within the bony orbit, which may cause exophthalmos. Studies of glaucoma patients reported periorbital fat atrophy after treatment with prostaglandin analogue drops. We hypothesize that owing to this side effect, prostaglandin analogue drops may benefit patients with TED-induced exophthalmos. DESIGN Interventional prospective pilot study. PARTICIPANTS Five adults with inactive… CONTINUE READING